JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8236 Regorafenib
4 Citation

Target: Raf|VEGFR|PDGFR|c-Kit|RET

Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1

≥25.04 mg/mL
A8246 BEZ235 (NVP-BEZ235)
2 Citation

Summary: PI3K/mTOR inhibitor,ATP-competitve

insoluble in DMSO; insoluble in EtOH; insoluble in H2O
A5118 BTZ043 Racemate
2 Citation

Target: DprE

Summary: DprE1 inhibitor

insoluble in H2O; ≥10.4 mg/mL
A8512 Rifaximin (Xifaxan)

Summary: RNA synthesis inhibitor, PXR activator

≥83.33 mg/mL
A8385 BMS265246

Target: Cyclin-Dependent Kinases

Summary: CDK1/2 inhibitor,potent and selective

insoluble in H2O; insoluble in EtOH; ≥17.25 mg/mL
A8567 Tenovin-3

Summary: p53 activator

insoluble in H2O; ≥14.45 mg/mL
A8601 Tankyrase Inhibitors (TNKS) 49

Target: Tankyrases

Summary: Tankyrase inhibitor

≥22.45 mg/mL
A9901 Caspase Inhibitor Set I

Summary: Caspase Inhibitors
B2290 Beta-Lapachone

Target: Topoisomerases

Summary: DNA topoisomerase I inhibitor,selective

insoluble in H2O; ≥10.85 mg/mL
B1515 Raloxifene HCl

Target: Estrogen and Related Receptors

Summary: Estrogen receptor (ER)

≥22.35 mg/mL